For the past 20 years, Innovaderm has been offering clinical research services of superior quality, serving its partners in their journey to discover new dermatology therapies and ultimately, help patients gain access to new and safe treatments.
Offer new therapies for patients living with skin diseases by partnering with the drug industry to support clinical research & development and by driving innovative internal research initiatives.
Innovation is within our name. We listen and remain open to ideas from colleagues, clients, and collaborators. We take every opportunity to challenge the status quo, to grow, and to make a positive impact on our employees, patients, clients and partners.
We work together as a team to achieve our common goals, recognizing that each member contributes their unique combination of strengths, knowledge, experience and perspective. Combining our expertise and skills makes us stronger.
Our commitment to each other, as well as all stakeholders, is not taken lightly. We act on our promises and respect established norms and procedures to deliver high-quality work. We can count on each other, and our partners can rely on us as well.
We are responsive and take action when needed. We react quickly and positively, never forsaking quality when we anticipate or face challenges or opportunities.
In 2000, Innovaderm began its activities as a clinical research site specialized in dermatology. Innovaderm has quickly built a strong reputation for the quality of its clinical research, the achievement of subject enrollment objectives and the care offered to its study participants.
In 2004, Innovaderm initiated strategic partnerships with research centers in the United States and Canada to offer its sponsors access to other high-quality dermatology sites. Since then, Innovaderm has built an excellent database of collaborating sites in North America.
In 2007, Innovaderm expanded its activities to include Clinical Research Organization (CRO) services for studies in dermatology. Our company offers a unique combination of a full-service CRO with advanced scientific capabilities and expert clinical site network.
Innovaderm is internationally renowned for its numerous research studies on psoriasis, acne and atopic dermatitis as well as for studies involving biologics and photodynamic therapy (PDT). Over 64% of our team comes from a life sciences background and over 55% has a postgraduate degree (Master, PhD and MD).
Our Executive Team
Robert Bissonnette, MD, FRCPC
Founder and CEO
Dr. Robert Bissonnette is the chief executive officer and medical director at Innovaderm, a company he established in 2000. For more than 20 years, Dr. Bissonnette has dedicated his efforts towards the advancement of dermatology research. Dr. Bissonnette has conducted nearly 200 studies ranging from proof-of-concept to phase III studies. As a Key Opinion Leader, he has extensive knowledge of clinical dermatology, clinical research, the dermatology market and is a great asset to our clients as he is able to offer a large perspective in the dermatology research field. He published more than 140 articles and book chapters and gives lectures on various aspects of dermatology at various national and international meetings. After graduating in Medicine from the University of Montreal, he completed his residency training in dermatology at the University of Montreal and his clinical research training at McGill University and the University of British Columbia. Dr. Bissonnette is a board-certified dermatologist and was an associate professor of dermatology at the University of Montreal until 2004. He is regularly solicited to participate on advisory board meetings for his expert opinion on clinical product development. Dr. Bissonnette is internationally renowned for his clinical expertise in atopic dermatitis and psoriasis.
Dave Selkirk serves as the Chief Operating Officer (COO) at Innovaderm, overseeing the CRO functions of Project Management, Clinical Operations, Biometrics, and Scientific Affairs, along with the CRU business unit which recruits and treats patients in-house for both early and later stage trials. Dave joined Innovaderm in March 2021 to lead our operational teams through significant growth. Dave is a seasoned industry executive with 29 years experience in pharmaceutical research. He has drug development expertise spanning Pre/Non-Clinical Research, Central and Specialty Labs, all phases of Clinical Research, Post-Approval and Market Access, as well as multiple modalities of Clinical Trial Technology. Prior to joining Innovaderm, Dave was the Founder and CEO of WhiteChurch Pharma & Biotech Consulting. For roughly two decades, he was employed at Covance in roles of increasing responsibility in Project Management, Business Unit Leadership with P&L responsibility, Strategy & Planning, and Alliance Management. Mid-way through his tenure at Covance, Dave worked for a little over a year as Vice President Alliance Management at Parexel.
Anne Marie Gaulin
Anne Marie Gaulin serves as the chief business officer at Innovaderm, overseeing business growth and facilitating the liaison between sponsors and our operational team for clinical research projects. Anne Marie joined Innovaderm as a director of business development in 2009. Since then, Anne Marie has contributed to the success and growth of the company by managing sales, marketing, the recruitment center, the CRO operations, the commercial development and she is also responsible for strategic planning. Her knowledge of dermatology clinical trials and more than 25 years of experience in the pharmaceutical industry is a great asset to our clients. Prior to joining Innovaderm, Anne Marie held a business development position at Cirion Biopharma, a central laboratory located in the Montreal area, an Operational management position at Alcan packaging, a company specialized in the packaging of pharmaceuticals and different sales and marketing positions in the pharmaceutical industry, including Rhône-Poulenc Rorer, now Sanofi and Sandoz Consumer Health, a division of Novartis.
VP, CRO Operations
Julie Bédard joined Innovaderm in 2014 in the role of Vice President, CRO Operations and has been overseeing all CRO operations services ever since. Prior to joining Innovaderm, Julie was holding the position of managing director of the Canadian office of a global mid-size CRO as well as leading the clinical trial management and monitoring group in the position of VP, Clinical trial operations for North America. She has over 22 years of experience in clinical research in a CRO environment including project management, clinical monitoring, clinical trial management and executive management. Julie holds a master’s degree in nutrition science from the University of Montreal.
Stephane Lussier recently joined Innovaderm as Vice President, Finance. His responsibilities include management of external and internal accounting, financial reporting, financial planning & analysis and tax. Stephane joined Innovaderm with more than 20 years of leadership experience in finance and operation roles in various industries in both medium and large businesses. Prior to joining Innovaderm, Stephane served as Senior director of finance in the aeronautic industry, managing the finance of the Canadian business unit of a large publicly traded company based in the USA. Stephane holds a bachelor’s degree in business administration from UQAM university. He is also a Certified Public Accountant (CPA-CMA).
VP, Information Technology & Support Services
Guillaume Gigon joined Innovaderm in 2018 and is now Vice President, Information Technology & Support Services. He is overseeing System Administration, Technical support, Information security and Computerized Systems Validation as well as Facility and Administrative Support. Prior to joining Innovaderm, Guillaume was holding different positions including managing director in a large CRO. He has over 15 years of experience in the clinical trial and biomedical industries including project management, validation and management. Guillaume holds a master’s degree in biochemical analysis, a DESS in Information Technology and multiple certifications including Certified CSTB Tester, LSS Green Belt and Portfolio Management.
Our team is fully invested in the development of your projects, striving to help you achieve success in your mission of improving patients’ lives. Our teams are devoted to applying custom solutions to the complex and ever-changing landscape of clinical research and development.
To overcome these challenges, our team, with their life-sciences background, is trained in dermatology and understands the intricacies of your clinical program. In addition, our Quality Assurance unit is dedicated to supporting your project throughout each step of its execution, endeavoring to meet high-standard quality controls.
Our continuous and rapid growth positions us to tackle the most difficult aspects of your dermatology clinical trials. We are always aiming to exceed your expectations, contact us to learn more about our capabilities.
We are located in Montreal, one of the largest and most multicultural cities in North America. Montreal is internationally renowned for its world-class education and for its large pool of diverse talent. Many of the world’s top research and technology institutions are located in Montreal, making it a remarkable science and innovation hub.
With its significant number of teaching hospitals, phase 1 units, laboratories and access to a large pool of research volunteers coming from diverse ethnic backgrounds, Montreal is a significant contributor to clinical research.
We have modern, state-of-the-art facilities that are conveniently located in downtown Montreal, 30 minutes away from the Montreal-Trudeau International Airport.